Clinical Trial

Effect of Nalbuphine Versus Fentanyl on Hemdoynamic Effects of Laryngoscopy

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated May 21, 2026 completion). Its status may not reflect the trial's current state.
Summary
Participants will undergo routine pre-operative evaluation. An intravenous line will be placed in the recovery area. On arrival in the operating room, standard monitoring (blood pressure, heart rate, oxygen saturation, ECG, breathing monitor, and temperature) will be applied. A central venous catheter and an arterial line will be inserted under local anesthesia using sterile technique. Before anesthesia induction, patients will receive premedication including midazolam and an opioid pain-relief injection given slowly through the vein. General anesthesia will then be induced with etomidate. After adequate sedation, a muscle relaxant (atracurium) will be administered, and the patient will be ventilated with 100% oxygen using a face mask. The breathing tube will then be inserted and correct placement confirmed. During surgery, anesthesia will be maintained with oxygen, sevoflurane gas, and a continuous atracurium infusion. Hemodynamic parameters such as heart rate and blood pressure will be monitored throughout the peri-intubation and intraoperative period.
Trial Details
NCT Number NCT07435337
Lead Sponsor Rawalpindi Institute of Cardiology
Conditions Laryngoscopy, Hemodynamic Changes
Enrollment 98 participants
Start Date 2026-02-21
Primary Completion 2026-05-21 (estimated)
Study Completion 2026-05-21 (estimated)
Updated on ClinicalTrials.gov 2026-02-27